TechNavio today launched its report Global Pneumococcal Vaccine Market 2011-2015 based on an in-depth study covering the Americas, and the EMEA and the APAC regions. The report aims to aid decision makers’ understanding of the significant trends impacting this market.
Commenting on the report, an analyst from TechNavio’s Healthcare team said: ”The vendors in the market have started targeting the elderly population in the developing nations in order to increase their market share in those countries. Moreover, there is large unmet demand for vaccines in developing nations. Furthermore, companies are planning to launch various vaccines in emerging markets in the near future to target the aging population along with the child population.”
According to the report, the increased awareness about and accessibility to pneumococcal vaccines in developing nations, where incidence and prevalence of pneumococcal diseases are comparatively higher than the developed nations, is one of the key drivers for the growth of the market.
Further, the report discusses that one of the key challenges is the emergence of regional players in developing countries, particularly in India and China.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key players. For further information on this report, please visit http://goo.gl/d60su
TechNavio, the market research platform of Infiniti Research Ltd, publishes periodic reports on niche and emerging technologies. For more information on our Healthcare market research, please visit https://www.technavio.com/healthcare
Follow us on Twitter @ Technavio
TechNavio Announces the Publication of its Report – Global Pneumococcal Vaccine Market 2011-2015
